Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
(NASDAQ: DTIL) Delayed: 6.98 -0.1 (1.41%)
Previous Close $7.08    52 Week High $ 
Open $6.98    52 Week Low $ 
Day High $7.30    P/E N/A 
Day Low $6.77    EPS $ 
Volume 132,681